{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:42:04Z","timestamp":1782924124235,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA114612"],"award-info":[{"award-number":["CA114612"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL55461"],"award-info":[{"award-number":["HL55461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jconrel.2008.06.017","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T04:33:48Z","timestamp":1214541228000},"page":"252-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["PTD-modified ATTEMPTS system for enhanced asparaginase therapy: A proof-of-concept investigation"],"prefix":"10.1016","volume":"130","author":[{"given":"Young Min","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun F.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chien","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2008.06.017_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2004.07.020","article-title":"Application of \u201cATTEMPTS\u201d for drug delivery","volume":"101","author":"Naik","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(01)00312-1","article-title":"Targeted delivery of antisense oligonucleotides in cancer","volume":"74","author":"Stuart","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-3659(01)00306-6","article-title":"Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function","volume":"74","author":"Jain","year":"2001","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0168-3659(94)90165-1","article-title":"Antibody-directed enzyme prodrug therapy (ADEPT)","volume":"28","author":"Bagshawe","year":"1994","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps020107","article-title":"Synthesis and characterization of positively charged tPA as a prodrug using heparin\/protamine-based drug delivery system","volume":"2","author":"Liang","year":"2000","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.jconrel.2008.06.017_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2008.06.017_bib7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2008.06.017_bib8","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/j.1460-2075.1991.tb07697.x","article-title":"Endocytosis and targeting of exogenous HIV-1 Tat protein","volume":"10","author":"Mann","year":"1991","journal-title":"Embo J"},{"key":"10.1016\/j.jconrel.2008.06.017_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nbt0598-440","article-title":"Intercellular delivery of functional p53 by the herpesvirus protein VP22","volume":"16","author":"Phelan","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jconrel.2008.06.017_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2008.06.017_bib11","doi-asserted-by":"crossref","first-page":"18188","DOI":"10.1074\/jbc.271.30.18188","article-title":"Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent","volume":"271","author":"Derossi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jconrel.2008.06.017_bib12","doi-asserted-by":"crossref","first-page":"10699","DOI":"10.1073\/pnas.94.20.10699","article-title":"Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4\/6 complexes results in active pRb","volume":"94","author":"Ezhevsky","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2008.06.017_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-3659(03)00212-8","article-title":"Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function","volume":"91","author":"Snyder","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-3659(03)00213-X","article-title":"Subcellular trafficking of HPMA copolymer\u2013Tat conjugates in human ovarian carcinoma cells","volume":"91","author":"Nori","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jconrel.2004.02.020","article-title":"Intracellular tracking of protamine\/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation","volume":"96","author":"Dinauer","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.jconrel.2008.06.017_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0003-9861(64)90032-3","article-title":"Tumor inhibitory effect of L-asparaginase from Escherichia coli","volume":"105","author":"Mashburn","year":"1964","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jconrel.2008.06.017_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1990.tb06336.x","article-title":"Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo","volume":"74","author":"Gugliotta","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jconrel.2008.06.017_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1992.tb00032.x","article-title":"Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group","volume":"49","author":"Gugliotta","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jconrel.2008.06.017_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.1987.5.5.811","article-title":"Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia","volume":"5","author":"Homans","year":"1987","journal-title":"J Clil Oncol"},{"key":"10.1016\/j.jconrel.2008.06.017_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0038-1661178","article-title":"L-asparaginase lowers protein C antigen","volume":"52","author":"Barbui","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jconrel.2008.06.017_bib21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0022-3476(82)80536-2","article-title":"The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia","volume":"100","author":"Priest","year":"1982","journal-title":"J Pediatr"},{"key":"10.1016\/j.jconrel.2008.06.017_bib22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI106579","article-title":"Immunological responses to L-asparaginase","volume":"50","author":"Peterson","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jconrel.2008.06.017_bib23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/1097-0142(197610)38:4<1843::AID-CNCR2820380463>3.0.CO;2-J","article-title":"Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures","volume":"38","author":"Dellinger","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2008.06.017_bib24","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1203\/00006450-198519040-00017","article-title":"Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children\u2014evidence of a complement-mediated mechanism","volume":"19","author":"Fabry","year":"1985","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jconrel.2008.06.017_bib25","first-page":"1","article-title":"Asparaginase as a drug for treatment of acute lymphoblastic leukaemia","volume":"24","author":"Gallagher","year":"1989","journal-title":"Essays Biochem"},{"key":"10.1016\/j.jconrel.2008.06.017_bib26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/oxfordjournals.jbchem.a129077","article-title":"Reaction of fluorescein-isothiocyanate with proteins and amino acids. I. Covalent and non-covalent binding of fluorescein-isothiocyanate and fluorescein to proteins","volume":"65","author":"Maeda","year":"1969","journal-title":"J Biochem (Tokyo)"},{"key":"10.1016\/j.jconrel.2008.06.017_bib27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/S0021-9258(19)42886-X","article-title":"Substrate binding and intersubunit interactions in L-asparaginase","volume":"249","author":"Shifrin","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jconrel.2008.06.017_bib28","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.jconrel.2008.06.017_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-1759(91)90114-U","article-title":"An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT","volume":"142","author":"Roehm","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jconrel.2008.06.017_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.160.3827.533","article-title":"Asparagine synthetase activity of mouse leukemias","volume":"160","author":"Horowitz","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2008.06.017_bib31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4049\/jimmunol.159.1.344","article-title":"Differential CD45 isoform expression accompanies reduced natural antibody binding in L5178Y-F9 tumor progression","volume":"159","author":"Zhang","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jconrel.2008.06.017_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-3659(95)00185-9","article-title":"Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly (ethylene glycol)","volume":"40","author":"Veronese","year":"1996","journal-title":"J Control Release,"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908003477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365908003477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:21:38Z","timestamp":1759159298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365908003477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0168365908003477"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.06.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTD-modified ATTEMPTS system for enhanced asparaginase therapy: A proof-of-concept investigation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2008.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}